Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | CASP6 | P55212 | 1/20 | 1.00 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.79 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.79 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.79 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | HPGD | P15428 | 4/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.77 |
| ▸ | TSHR | P16473 | 3/20 | 0.77 |
| ▸ | TP53 | P04637 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 5/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.66 |
| ▸ | MAOA | P21397 | 4/20 | 0.66 |
| ▸ | S100A4 | P26447 | 2/20 | 0.57 |
| ▸ | PTPRC | P08575 | 1/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5109566 | 0.89 | MAPT (0.79) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL29644991 | 0.89 | CSNK2A2 (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL16656215 | 0.89 | CSNK2A2 (0.88) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL11135123 | 0.89 | CSNK2A2 (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL3519179 | 0.89 | CSNK2A2 (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL28116340 | 0.87 | CSNK2A2 (0.86) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL3501895 | 0.87 | TSHR (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL10356144 | 0.87 | TSHR (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL186885 | 0.87 | TSHR (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 | |
| SCHEMBL10356103 | 0.87 | TSHR (1.00) | MAPTPOLBAPEX1CASP6CSNK2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119297188-A | Preparation method of nanosheet-organic active molecule-catalyst hybrid material and application of nanosheet-organic active molecule-catalyst hybrid material in photoelectric storage integrated battery | 中国科学院大连化学物理研究所 | 2025-01-10 | — | — | CN | claimed |
| CN-119253090-A | Zn-I2Battery electrolyte and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2025-01-03 | — | — | CN | claimed |
| EP-0021264-B1 | PROCESS FOR THE DELIGNIFICATION OF LIGNOCELLULOSIC MATERIALS | BAYER AG (DE) | 1983-01-19 | — | — | EP | claimed |
| CN-119253090-A | Zn-I2Battery electrolyte and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2025-01-03 | — | — | CN | disclosed |
| EP-2537186-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2012-12-26 | — | — | EP | disclosed |
| CN-102844886-A | Use of indanthrene compounds in organic photovoltaics | BASF SE | 2012-12-26 | — | — | CN | disclosed |
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| WO-2011101810-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | WO | disclosed |
| US-7722784-B2 | Liquid crystal composition, liquid crystal device, reflection display material, light modulating material, and anthraquinone compound | FUJIFILM CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7722784-B2 | Liquid crystal composition, liquid crystal device, reflection display material, light modulating material, and anthraquinone compound | FUJIFILM CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7722784-B2 | Liquid crystal composition, liquid crystal device, reflection display material, light modulating material, and anthraquinone compound | FUJIFILM CORPORATION (JP) | 2010-05-25 | — | — | US | disclosed |
| CN-1379763-A | Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions | SIGNAL PHARM INC (US) | 2002-11-13 | — | — | CN | disclosed |
| EP-1218347-A1 | PYRAZOLOANTHRONE AND DERIVATIVES THEREOF AS JNK INHIBITORS AND THEIR COMPOSITIONS | SIGNAL PHARMACEUTICALS, INC. (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001012609-A1 | PYRAZOLOANTHRONE AND DERIVATIVES THEREOF AS JNK INHIBITORS AND THEIR COMPOSITIONS | SIGNAL PHARMACEUTICALS, INC. (US) | 2001-02-22 | — | — | WO | disclosed |
| EP-0103095-B1 | DICHROIC MATERIAL CONTAINING ANTHRAQUINONE DYES | BAYER AG (DE) | 1990-08-29 | — | — | EP | disclosed |
| EP-0103095-A2 | Dichroic material containing anthraquinone dyes | BAYER AG (DE) | 1984-03-21 | — | — | EP | disclosed |
| EP-0021264-B1 | PROCESS FOR THE DELIGNIFICATION OF LIGNOCELLULOSIC MATERIALS | BAYER AG (DE) | 1983-01-19 | — | — | EP | disclosed |
| US-4350566-A | DIGESTION; WOOD PULPING; PAPERMAKING | BAYER AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
| EP-0021264-A1 | Process for the delignification of lignocellulosic materials | BAYER AG (DE) | 1981-01-07 | — | — | EP | disclosed |
| US-4006171-A | FROM NITROANTHRAQUINONE AND HALOGEN | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | ICMT, EPCAM, INF2 | MAPT 266/4885POLB 2736/4885APEX1 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.